×

Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors

  • US 7,771,729 B2
  • Filed: 07/05/2006
  • Issued: 08/10/2010
  • Est. Priority Date: 04/28/2000
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method of potentiating a CD8+ response to human immunodeficiency virus-1 (HIV-1) epitopes in a human comprising:

  • administering an expression vector encoding HIV-1 Gag, Pol, Pro, Tat, Nef, Rev, Vif, Vpr or Env antigens; and

    administering a recombinant ALVAC pox virus encoding the same antigens encoded by the expression vector;

    wherein the expression vector and the recombinant pox virus enter the cells of the humanand intracellularly produce HIV peptides that are presented on the cell'"'"'s MHC class I molecules in an amount sufficient to stimulate a CD8+ response, and further, wherein administration of the combination of the expression vector and the recombinant pox virus potentiates the immune response compared to administration of either the expression vector or the recombinant pox virus by itself.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×